These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24885363)

  • 1. Increased expression of stathmin and elongation factor 1α in precancerous nodules with telomere dysfunction in hepatitis B viral cirrhotic patients.
    Ahn EY; Yoo JE; Rhee H; Kim MS; Choi J; Ko JE; Lee JS; Park YN
    J Transl Med; 2014 May; 12():154. PubMed ID: 24885363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal instability, telomere shortening, and inactivation of p21(WAF1/CIP1) in dysplastic nodules of hepatitis B virus-associated multistep hepatocarcinogenesis.
    Lee YH; Oh BK; Yoo JE; Yoon SM; Choi J; Kim KS; Park YN
    Mod Pathol; 2009 Aug; 22(8):1121-31. PubMed ID: 19465904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis.
    Oh BK; Kim YJ; Park YN; Choi J; Kim KS; Park C
    Am J Gastroenterol; 2006 Apr; 101(4):831-8. PubMed ID: 16494581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis.
    Oh BK; Kim YJ; Park C; Park YN
    Am J Pathol; 2005 Jan; 166(1):73-80. PubMed ID: 15632001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis.
    Oh BK; Jo Chae K; Park C; Kim K; Jung Lee W; Han KH; Nyun Park Y
    J Hepatol; 2003 Nov; 39(5):786-92. PubMed ID: 14568262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 and p21WAF1/CIP1 in hepatitis B virus related hepatocarcinogenesis.
    Park YN; Chae KJ; Kwon KW; Oh BK; Lee KS; Lee WJ; Park C
    Hepatogastroenterology; 2003; 50(53):1292-6. PubMed ID: 14571721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis and proliferation in hepatocarcinogenesis related to cirrhosis.
    Park YN; Chae KJ; Kim YB; Park C; Theise N
    Cancer; 2001 Dec; 92(11):2733-8. PubMed ID: 11753945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squamous cell carcinoma antigen in human liver carcinogenesis.
    Guido M; Roskams T; Pontisso P; Fassan M; Thung SN; Giacomelli L; Sergio A; Farinati F; Cillo U; Rugge M
    J Clin Pathol; 2008 Apr; 61(4):445-7. PubMed ID: 17893121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of DNA methyltransferases in multistep hepatocarcinogenesis.
    Choi MS; Shim YH; Hwa JY; Lee SK; Ro JY; Kim JS; Yu E
    Hum Pathol; 2003 Jan; 34(1):11-7. PubMed ID: 12605361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large liver cell change in hepatitis B virus-related liver cirrhosis.
    Kim H; Oh BK; Roncalli M; Park C; Yoon SM; Yoo JE; Park YN
    Hepatology; 2009 Sep; 50(3):752-62. PubMed ID: 19585549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region.
    Sun M; Eshleman JR; Ferrell LD; Jacobs G; Sudilovsky EC; Tuthill R; Hussein MR; Sudilovsky O
    Hepatology; 2001 Jun; 33(6):1415-24. PubMed ID: 11391530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma.
    Joung JG; Ha SY; Bae JS; Nam JY; Gwak GY; Lee HO; Son DS; Park CK; Park WY
    Oncotarget; 2017 Jan; 8(2):2076-2082. PubMed ID: 27409339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis.
    Plentz RR; Park YN; Lechel A; Kim H; Nellessen F; Langkopf BH; Wilkens L; Destro A; Fiamengo B; Manns MP; Roncalli M; Rudolph KL
    Hepatology; 2007 Apr; 45(4):968-76. PubMed ID: 17393506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus-associated multistep hepatocarcinogenesis: a stepwise increase in allelic alterations.
    Lee JM; Wong CM; Ng IO
    Cancer Res; 2008 Jul; 68(14):5988-96. PubMed ID: 18632655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis.
    Um TH; Kim H; Oh BK; Kim MS; Kim KS; Jung G; Park YN
    J Hepatol; 2011 May; 54(5):939-47. PubMed ID: 21145824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central role of c-Myc during malignant conversion in human hepatocarcinogenesis.
    Kaposi-Novak P; Libbrecht L; Woo HG; Lee YH; Sears NC; Coulouarn C; Conner EA; Factor VM; Roskams T; Thorgeirsson SS
    Cancer Res; 2009 Apr; 69(7):2775-82. PubMed ID: 19276364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic evaluation of the dysplasia-carcinoma sequence in chronic viral liver disease: a detailed analysis of two cases and a review of the literature.
    van Dekken H; Wink J; Alers JC; de Man RA; IJzermans JN; Zondervan PE
    Acta Histochem; 2003; 105(1):29-41. PubMed ID: 12666986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16 Hypermethylation in the early stage of hepatitis B virus-associated hepatocarcinogenesis.
    Shim YH; Yoon GS; Choi HJ; Chung YH; Yu E
    Cancer Lett; 2003 Feb; 190(2):213-9. PubMed ID: 12565176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.